UniProt ID | ERRFI_HUMAN | |
---|---|---|
UniProt AC | Q9UJM3 | |
Protein Name | ERBB receptor feedback inhibitor 1 | |
Gene Name | ERRFI1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 462 | |
Subcellular Localization |
Cytoplasm . Cell membrane Peripheral membrane protein Cytoplasmic side. Nucleus. Associated with the plasma membrane of basal skin keratinocytes. Translocates into the nucleus of differentiating suprabasal keratinocytes (By similarity).. |
|
Protein Description | Negative regulator of EGFR signaling in skin morphogenesis. Acts as a negative regulator for several EGFR family members, including ERBB2, ERBB3 and ERBB4. Inhibits EGFR catalytic activity by interfering with its dimerization. Inhibits autophosphorylation of EGFR, ERBB2 and ERBB4. Important for normal keratinocyte proliferation and differentiation. Plays a role in modulating the response to steroid hormones in the uterus. Required for normal response to progesterone in the uterus and for fertility. Mediates epithelial estrogen responses in the uterus by regulating ESR1 levels and activation. Important for regulation of endometrium cell proliferation. Important for normal prenatal and perinatal lung development (By similarity).. | |
Protein Sequence | MSIAGVAAQEIRVPLKTGFLHNGRAMGNMRKTYWSSRSEFKNNFLNIDPITMAYSLNSSAQERLIPLGHASKSAPMNGHCFAENGPSQKSSLPPLLIPPSENLGPHEEDQVVCGFKKLTVNGVCASTPPLTPIKNSPSLFPCAPLCERGSRPLPPLPISEALSLDDTDCEVEFLTSSDTDFLLEDSTLSDFKYDVPGRRSFRGCGQINYAYFDTPAVSAADLSYVSDQNGGVPDPNPPPPQTHRRLRRSHSGPAGSFNKPAIRISNCCIHRASPNSDEDKPEVPPRVPIPPRPVKPDYRRWSAEVTSSTYSDEDRPPKVPPREPLSPSNSRTPSPKSLPSYLNGVMPPTQSFAPDPKYVSSKALQRQNSEGSASKVPCILPIIENGKKVSSTHYYLLPERPPYLDKYEKFFREAEETNGGAQIQPLPADCGISSATEKPDSKTKMDLGGHVKRKHLSYVVSP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSIAGVAAQ ------CCCCCCEEE | 22.58 | 22814378 | |
33 | Phosphorylation | MGNMRKTYWSSRSEF CCCCHHHHCCCHHHH | 13.31 | - | |
54 | Phosphorylation | IDPITMAYSLNSSAQ CCHHHEEEECCCCHH | 11.67 | 25159151 | |
71 | Phosphorylation | LIPLGHASKSAPMNG EEECCCCCCCCCCCC | 22.82 | 23312004 | |
73 | Phosphorylation | PLGHASKSAPMNGHC ECCCCCCCCCCCCCC | 34.80 | 28985074 | |
116 | Acetylation | DQVVCGFKKLTVNGV CCEEECCEEEEECCE | 31.96 | 24468295 | |
119 | Phosphorylation | VCGFKKLTVNGVCAS EECCEEEEECCEECC | 22.32 | 23403867 | |
126 | Phosphorylation | TVNGVCASTPPLTPI EECCEECCCCCCCCC | 36.00 | 27273156 | |
127 | Phosphorylation | VNGVCASTPPLTPIK ECCEECCCCCCCCCC | 15.48 | 27273156 | |
131 | Phosphorylation | CASTPPLTPIKNSPS ECCCCCCCCCCCCCC | 28.83 | 27273156 | |
136 | Phosphorylation | PLTPIKNSPSLFPCA CCCCCCCCCCCCCCH | 15.74 | 21815630 | |
138 | Phosphorylation | TPIKNSPSLFPCAPL CCCCCCCCCCCCHHH | 42.32 | 22199227 | |
176 | Phosphorylation | CEVEFLTSSDTDFLL CEEEEECCCCCCEEE | 28.50 | - | |
193 | Phosphorylation | STLSDFKYDVPGRRS CCCCCCCCCCCCCCC | 23.36 | - | |
224 | Phosphorylation | VSAADLSYVSDQNGG CCHHHHHHCCCCCCC | 15.98 | - | |
249 | Phosphorylation | THRRLRRSHSGPAGS HHHHHHHHCCCCCCC | 18.64 | 23927012 | |
251 | Phosphorylation | RRLRRSHSGPAGSFN HHHHHHCCCCCCCCC | 47.95 | 20201521 | |
256 | Phosphorylation | SHSGPAGSFNKPAIR HCCCCCCCCCCCEEE | 27.96 | 23927012 | |
265 | Phosphorylation | NKPAIRISNCCIHRA CCCEEEEECCEEEEC | 17.61 | 28985074 | |
273 | Phosphorylation | NCCIHRASPNSDEDK CCEEEECCCCCCCCC | 25.27 | 29255136 | |
276 | Phosphorylation | IHRASPNSDEDKPEV EEECCCCCCCCCCCC | 45.84 | 29255136 | |
302 | Phosphorylation | KPDYRRWSAEVTSST CCCHHCCEEEECCCC | 16.85 | 22617229 | |
306 | Phosphorylation | RRWSAEVTSSTYSDE HCCEEEECCCCCCCC | 14.41 | 29978859 | |
307 | Phosphorylation | RWSAEVTSSTYSDED CCEEEECCCCCCCCC | 26.34 | 29978859 | |
308 | Phosphorylation | WSAEVTSSTYSDEDR CEEEECCCCCCCCCC | 23.23 | 29978859 | |
309 | Phosphorylation | SAEVTSSTYSDEDRP EEEECCCCCCCCCCC | 27.15 | 29978859 | |
310 | Phosphorylation | AEVTSSTYSDEDRPP EEECCCCCCCCCCCC | 18.97 | 23312004 | |
311 | Phosphorylation | EVTSSTYSDEDRPPK EECCCCCCCCCCCCC | 34.31 | 23312004 | |
326 | Phosphorylation | VPPREPLSPSNSRTP CCCCCCCCCCCCCCC | 36.68 | 29255136 | |
328 | Phosphorylation | PREPLSPSNSRTPSP CCCCCCCCCCCCCCC | 44.02 | 29116813 | |
330 | Phosphorylation | EPLSPSNSRTPSPKS CCCCCCCCCCCCCCC | 41.70 | 29116813 | |
332 | Phosphorylation | LSPSNSRTPSPKSLP CCCCCCCCCCCCCCH | 28.12 | 29116813 | |
334 | Phosphorylation | PSNSRTPSPKSLPSY CCCCCCCCCCCCHHH | 44.33 | 29116813 | |
337 | Phosphorylation | SRTPSPKSLPSYLNG CCCCCCCCCHHHHCC | 49.23 | 28188228 | |
340 | Phosphorylation | PSPKSLPSYLNGVMP CCCCCCHHHHCCCCC | 47.77 | 22199227 | |
341 | Phosphorylation | SPKSLPSYLNGVMPP CCCCCHHHHCCCCCC | 11.40 | 27259358 | |
358 | Phosphorylation | SFAPDPKYVSSKALQ CCCCCHHHCCHHHHH | 15.79 | - | |
361 | Phosphorylation | PDPKYVSSKALQRQN CCHHHCCHHHHHHCC | 16.35 | - | |
362 | Ubiquitination | DPKYVSSKALQRQNS CHHHCCHHHHHHCCC | 45.68 | - | |
369 | Phosphorylation | KALQRQNSEGSASKV HHHHHCCCCCCHHCC | 34.69 | 23927012 | |
372 | Phosphorylation | QRQNSEGSASKVPCI HHCCCCCCHHCCCEE | 25.89 | 22777824 | |
374 | Phosphorylation | QNSEGSASKVPCILP CCCCCCHHCCCEEEE | 35.56 | 22777824 | |
390 | Phosphorylation | IENGKKVSSTHYYLL EECCEEEEECEEEEC | 38.10 | 28152594 | |
391 | Phosphorylation | ENGKKVSSTHYYLLP ECCEEEEECEEEECC | 23.38 | 28152594 | |
392 | Phosphorylation | NGKKVSSTHYYLLPE CCEEEEECEEEECCC | 13.34 | 28152594 | |
394 | Phosphorylation | KKVSSTHYYLLPERP EEEEECEEEECCCCC | 8.90 | 27273156 | |
395 | Phosphorylation | KVSSTHYYLLPERPP EEEECEEEECCCCCC | 8.31 | 25159151 | |
403 | Phosphorylation | LLPERPPYLDKYEKF ECCCCCCCHHHHHHH | 30.16 | 27259358 | |
407 | Phosphorylation | RPPYLDKYEKFFREA CCCCHHHHHHHHHHH | 24.82 | 27642862 | |
457 | Phosphorylation | HVKRKHLSYVVSP-- CEECEEEEEEECC-- | 18.66 | 28442448 | |
458 | Phosphorylation | VKRKHLSYVVSP--- EECEEEEEEECC--- | 15.95 | 25159151 | |
461 | Phosphorylation | KHLSYVVSP------ EEEEEEECC------ | 18.17 | 28355574 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
251 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
302 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
394 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
395 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:27557663 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERRFI_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERRFI_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-461, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-394 AND TYR-395, ANDMASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-394 AND TYR-395, ANDMASS SPECTROMETRY. |